CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
autoRIC® devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03400579
NCT03400579N/ACompleted

A Pilot Study of the Feasibility of Prehospital Delivery of Remote Ischemic Conditioning by Emergency Medical Services in Chest Pain Patients

University of North Carolina, Chapel Hill·interventional·Posted Jan 17, 2018·Updated Sep 1, 2020

In Brief

A clinical study evaluating autoRIC® device for Chest Pain. Completed, enrolled 10 participants across 1 site.

Detailed Summary

Prospective, single center, single arm pilot study evaluating the feasibility of delivering remote ischemic conditioning (RIC) by emergency medical services (EMS) in the prehospital setting. Eligible patients will have chest pain or anginal equivalent symptoms and require ground ambulance transport to the hospital. All subjects will undergo the standard RIC procedure (i.e., up to four cycles of alternating 5-min inflation and 5-min deflation) with the autoRIC® device (CellAegis Devices, Inc., Toronto, Ontario). The primary objective is to evaluate the number of cycles of RIC completed in patients having the procedure initiated by EMS in the prehospital setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChest Pain
CountriesUnited States

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 17, 2018
Enrollment StartJul 10, 2018
Primary CompletionSep 30, 2019
Study CompletionOct 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.5 years ago

Interventions

autoRIC® devicedevice

The autoRIC® automatically delivers four RIC cycles of five minutes of pressure at 200 mm Hg followed by five minutes of no pressure for a total 40-min treatment period